Menu Close

How Are 19 Pharmaceutical Brands Driving Successful Digital Transformation, Automation & Innovation Across The Pharma Value Chain?

Power Digital Transformation Momentum In Pharma For Better Customer Outcomes: Driving Digital Transformation, Innovation & Automation Across The Pharma Value Chain

Reimagine The Pharma Industry With A Focus On: AI & Automation – Data ✓ Culture Change ✓ Manufacturing ✓ Clinical Trials ✓ Digital Health ✓ Omni-Channel ✓ Processes ✓ Regulation. A One-Day, Industry-Led Conference & Networking Event, 25th November 2021, Virtually

GIC Pharma Transformation - Header-02

8.30 Registration, Informal Networking & GIC Opening Remarks

09.00 Morning Co-Chairs’ Opening Remarks

Andreas Panteli, Director, Digital Integrated Solutions, Novartis

Massimo Buonaiuto, EMEA Principal Scientist In Data Science & Digital Transformation, DSM

AI & MACHINE LEARNING

09.10 Successfully Leverage Automation, AI & ML Technologies To Reimagine Pharma For The Benefit Of The End Customer

  • What are the leading examples of AI and automation application within pharma digital transformation that have been pivotal in industry progress?
  • What are the key challenges and blockers when it comes to embedding AI and how can these be best tackled?
  • Decipher which model of machine learning fits your business needs best
  • How can you keep up with the latest regulatory frameworks around AI and ML technologies which are constantly updating?

Massimo Buonaiuto, EMEA Principal Scientist In Data Science & Digital Transformation, DSM

AUTOMATION & ROBOTICS - Q&A PANEL

09.30 Capitalise On Evolving Automation, RPA& New Technologies & Digital Innovations For A Fit-For-Future, Relevant Pharma Business Q&A

  • Success stories and lessons learnt: new case studies of automation in pharma to smoothly implement and integrate automation into the workplace for efficient processes
  • Human, robot, cobot: where does the optimum balance lie in automating processes?
  • Look beyond the pharma world for lessons learnt from other regulated industries that are further ahead in their automation journey

Padraig Maree, Automation Lead, Pfizer

Peter Speyer, Head of Customer Success, data42, Novartis

Massimo Buonaiuto, EMEA Principal Scientist In Data Science & Digital Transformation, DSM

Anna Marchenko, Senior Manager Digital Innovation, GSK

Uros Klancar, Head Global Pipeline & Portfolio Digital Strategy, Sandoz

10.00 Bonus Session; Reserved For Exclusive Conference Partner

10.40 Morning Refreshment Break With Informal Networking

CULTURE CHANGE & LEADERSHIP BUY-IN - Q&A PANEL

11.10 Successfully Manage Change, Engage Leadership & Encourage Agile, Digital Mindsets For Smooth Digital Adoption Across The Entire Organisation

  • In today’s age where digital innovation is business-critical, how can you ensure the workforce is prepared to embrace digital change?
  • It’s no secret that people can be a blocker in transformation: from the shop floor to middle management, ensure everyone understands the importance and benefits of digital transformation for pharma
  • Combatting mistrust in validation automation and digital fatigue
  • Culture change must come from the top! Get leadership fully on board with the digital strategy and prove the impact of new technologies for ongoing investment and support

Uros Klancar, Head Global Pipeline & Portfolio Digital Strategy, Sandoz

Samuel Driessen, Senior Director External Digital Channels & Content, Teva Pharmaceuticals

Nadir Ammour, Global Lead External Engagement, Clinical Innovation Office, Sanofi

Myles Furnace, Digital Health & Data Lead, Ipsen

Anna Marchenko, Senior Manager Digital Innovation, GSK

Dr. Henning Trill, VP Innovation Strategy, Bayer

DATA & ANALYTICS - CASE STUDY

11.40 Accelerating Digitalisation To Better Gather, Analyse & Manage Data & Derive Meaningful Insights To Inform Decisions

  • In the age of data-led pharma, understand how new data techniques and improved analytics can enrich future innovation
  • AI and big data: what data is needed and how must it be structured in order to fully realise AI’s potential in pharma?
  • From data mining to predictive analytics, ensure you are optimising data analytics for accurate insights
  • Steps to ensure watertight governance and security through every step of data handling

Laura Cirillo, Head of Digital & Innovation, AstraZeneca

PATIENT-CENTRIC INNOVATION

12.00 Put Patients At The Heart Of Your Digital Transformation With Customer-Centric Tools & Innovations That Boost Engagement & Improve Patient Outcomes

  • When the end customer is the patient, how are you ensuring your digital strategy brings real value to them?
  • With patients having more of a say in their treatment than ever before, ensure you are keeping up with innovation sparked by the patient
  • How can you better work with patient advocacy groups for further benefit to the patient from digitalisation?

Sander Ruitenberg, Global Digital Health Solutions Head, Novartis

12.20 Lunch For Speakers, Delegates & Partners

12.50 Informal Peer-To-Peer Breakout Discussions

A) Digital Twins
Padraig Maree, Automation Lead, Pfizer

B) Real World Evidence
Peter Speyer, Head of Customer Success, data42, Novartis

C) Business Processes
Dr Frank Thielmann, Operational Excellence Director & Head Business Excellence - Region Europe, Takeda

D) Patient Recruitment
Nick Carroll, Transformation Lead, Digital Health, R&D, AstraZeneca

E) Digital Labs
Massimo Buonaiuto, EMEA Principal Scientist In Data Science & Digital Transformation, DSM

F) Sustainability
Nadir Ammour, Global Lead External Engagement, Clinical Innovation Office, Sanofi

G) Digital Clinical Trials

13.20 Afternoon Co-Chairs’ Opening Remarks
Nick Carroll, Transformation Lead, Digital Health, R&D, AstraZeneca

Dario Floris, Country Business Unit Head, Merck

DIGITAL HEALTH

13.30 Capitalise On Digital Health, Digital Therapeutics & Wearables Advances To Enrich Patient Outcomes & Experiences

  • How can you ensure you are doing digital health right for the patient and seeing a return on investment?
  • Collaborate with off-the-shelf wearables and medical devices for up-to-date continuous monitoring and real-world evidence
  • What are the current routes to market and where are the commercial successes of digital therapeutics so far?
  • Successfully work with patient advocacy groups to ensure further adoption of digital therapeutics, new medical devices and apps to enhance patient outcomes

Bernard Gauthier, ITS Business Partner France GBU – General Medicine, Sanofi

 

END-TO-END PHARMA DIGITAL TRANSFORMATION - DOUBLE PERSPECTIVE

13.50 Share The Challenges, Successes & Lessons Learnt Of A Digital Transformation & Innovation Journey Within Pharma

  • What does the rough, bumpy road of digital transformation actually look like across the pharma business?
  • What were the key hurdles to overcome in your recent digital transformation?
  • How can you strive for digital innovation in such a heavily-regulated, siloed and traditional environment?

13.50 Perspective One
Nadia Stroungari, Digital Business Transformation Lead - Eastern Europe, UCB

14.10 Perspective Two
Nick Lagan, Global Head of Digital Platforms, Grünenthal Group

14.30 Bonus Session; Reserved For Exclusive Conference Partner

15.00 Afternoon Refreshment Break With Informal Networking

MANUFACTURING & INDUSTRY 4.0

15.30 Embrace New Opportunities For Manufacturing In The Age Of Industry 4.0

  • From personalised medicine to operational efficiencies, harness the power of digital transformation to achieve new manufacturing goals in the age of industry 4.0
  • Best-practice advice on implementing new technologies and encouraging adoption in one of pharma’s most conservative areas
  • How to map out the start of the digital transformation journey when updating outdated legacy systems and factory production lines

OMNI-CHANNEL CUSTOMER & STAKEHOLDER ENGAGEMENT - Q&A PANEL

15.50 Strive For Digital & Omni-Channel Excellence To Maximise Engagement Q&A With Patients, HCPs & Stakeholders Alike

  • After a year of digital acceleration, how can you ensure your comms and channel strategies are truly omni-channel and guarantee vulnerable patients are included?
  • Telemedicine, Webinars, Podcasts... the list goes on! Successfully integrate relevant new channels into your existing portfolio for omni-channel excellence
  • Harness patient, HCP and stakeholder insights to create better experiences that build long-term relationships
  • What KPIs are needed to assess engagement performance, understand pain points and further engage stakeholders?

Samik Adhikary, Head of AI & Data Science In Global Product Strategy, Roche

Nadia Stroungari, Digital Business Transformation Lead - Eastern Europe, UCB

Samuel Driessen, Senior Director External Digital Channels & Content, Teva Pharmaceuticals

Gaetan Akinrolabu, Director of Paid Media and Social Media Strategy, Bristol Myers Squibb

16.20 Afternoon Co-Chairs’ Closing Remarks

16.30 Official Close Of Conference